The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Amazon Pharmacy is streamlining GLP-1 access by adding Zepbound KwikPen to its same-day delivery service. This multi-dose device holds a full month's supply, addressing manufacturing bottlenecks and offering $299 cash-pay pricing—far below traditional $1,000 quotes. Integrated with Amazon One Medical, it provides personalized care for weight management and obstructive sleep apnea patients.
South Africa's Aspen Pharmacare is accelerating Mounjaro's rollout across sub-Saharan Africa after its explosive success at home, where the GLP-1 market tripled to $133.6 million. With over half the market share and $78.97 million in projected sales, this expansion tests rapid access to advanced weight-loss therapies. Here's how Aspen's KwikPen approval paves the way.
In a surprise turn, Novo Nordisk is dropping its lawsuit against Hims & Hers Health, paving the way for branded Wegovy and Ozempic sales on the telehealth platform. This follows Hims' brief plan for cheaper compounded versions and FDA warnings on shortages. Patients gain better access to approved GLP-1 medications.
With surging demand for GLP-1 drugs in India, the All India Organisation of Chemists and Druggists (AIOCD) has issued a strict reminder to its 12.4 lakh members: sell obesity and diabetic GLP-1 medications, including injectables, only against valid prescriptions from qualified practitioners. This comes as pharma giants like Eli Lilly promote awareness for proper treatment. Understand the implications for patients seeking Tirzepatide brands like Mounjaro and Zepbound.
New research reveals GLP-1 medications like Ozempic may significantly elevate risks of bone disorders and tendon injuries. Analyzing nearly 150,000 patients, the study found 30% higher osteoporosis rates and 50% increased tendon rupture risks over five years. Experts urge bone density monitoring amid these findings.
A groundbreaking study in the British Medical Journal reveals that GLP-1 drugs like Ozempic offer benefits far beyond weight loss and diabetes control—they significantly reduce risks of alcohol, tobacco, cannabis, and cocaine abuse. Among 606,434 US veterans with type 2 diabetes, these medications lowered substance abuse risks by up to 20%. Experts caution that while promising, more research is needed.
Jessica Simpson, the 45-year-old star who rose to fame at 19 with 'I Wanna Love You Forever,' has fans buzzing over her transformed appearance. Speculation points to 'Ozempic face'—sunken eyes, sagging skin from GLP-1 drugs—but Simpson insists it's all willpower and healthy habits after losing 100 pounds post-pregnancy.
Meghan Trainor's striking transformation, showcased in side-by-side photos from 2014 and 2025, has ignited debates on 'Ozempic face' from GLP-1 drugs like Mounjaro. While her defined jawline looks stunning, experts note rapid fat loss can accelerate aging signs like sunken cheeks and wrinkles. Learn the facts amid body positivity backlash.
Patients on GLP-1 drugs like Ozempic report losing interest in cigarettes, alcohol, and more without effort. A physician-led study of over 600,000 VA patients reveals these medications cut addiction-related deaths by 50% and prevent new substance use disorders. This could transform treatment for alcohol, opioids, cocaine, cannabis, and nicotine.
